These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29723147)

  • 21. Comparison of myeloperoxidase and hemi-myeloperoxidase with respect to catalysis, regulation, and bactericidal activity.
    Andrews PC; Parnes C; Krinsky NI
    Arch Biochem Biophys; 1984 Feb; 228(2):439-42. PubMed ID: 6320739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of ceruloplasmin with eosinophil peroxidase as compared to its interplay with myeloperoxidase: Reciprocal effect on enzymatic properties.
    Sokolov AV; Kostevich VA; Zakharova ET; Samygina VR; Panasenko OM; Vasilyev VB
    Free Radic Res; 2015 Jun; 49(6):800-11. PubMed ID: 25762223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils.
    Rosen H; Klebanoff SJ; Wang Y; Brot N; Heinecke JW; Fu X
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18686-91. PubMed ID: 19833874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assembly of dimeric myeloperoxidase during posttranslational maturation in human leukemic HL-60 cells.
    Taylor KL; Guzman GS; Burgess CA; Kinkade JM
    Biochemistry; 1990 Feb; 29(6):1533-9. PubMed ID: 2159341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boronate-Based Oxidant-Responsive Derivatives of Acetaminophen as Proinhibitors of Myeloperoxidase.
    Pierzchała K; Pięta J; Pięta M; Rola M; Zielonka J; Sikora A; Marcinek A; Michalski R
    Chem Res Toxicol; 2023 Aug; 36(8):1398-1408. PubMed ID: 37534491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH-dependent regulation of myeloperoxidase activity.
    Vlasova II; Arnhold J; Osipov AN; Panasenko OM
    Biochemistry (Mosc); 2006 Jun; 71(6):667-77. PubMed ID: 16827659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic method for assaying the halogenating activity of myeloperoxidase based on reaction of celestine blue B with taurine halogenamines.
    Sokolov AV; Kostevich VA; Kozlov SO; Donskyi IS; Vlasova II; Rudenko AO; Zakharova ET; Vasilyev VB; Panasenko OM
    Free Radic Res; 2015 Jun; 49(6):777-89. PubMed ID: 25790937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.
    Jantschko W; Furtmüller PG; Zederbauer M; Neugschwandtner K; Lehner I; Jakopitsch C; Arnhold J; Obinger C
    Biochem Pharmacol; 2005 Apr; 69(8):1149-57. PubMed ID: 15794935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloperoxidase in kidney disease.
    Malle E; Buch T; Grone HJ
    Kidney Int; 2003 Dec; 64(6):1956-67. PubMed ID: 14633118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of myeloperoxidase-mediated oxidative damage by nitrite in SH-SY5Y cells: Relevance to neuroprotection in neurodegenerative diseases.
    Lu N; Ding Y; Tian R; Peng YY
    Eur J Pharmacol; 2016 Jun; 780():142-7. PubMed ID: 27020551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloperoxidase-catalyzed taurine chlorination: initial versus equilibrium rate.
    Ramos DR; Victoria García M; Canle L M; Arturo Santaballa J; Furtmüller PG; Obinger C
    Arch Biochem Biophys; 2007 Oct; 466(2):221-33. PubMed ID: 17868637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant binding of caeruloplasmin to myeloperoxidase: myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact.
    Park YS; Suzuki K; Mumby S; Taniguchi N; Gutteridge JM
    Free Radic Res; 2000 Sep; 33(3):261-5. PubMed ID: 10993479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fluorescent homogeneous assay for myeloperoxidase measurement in biological samples. A positive correlation between myeloperoxidase-generated HOCl level and oxidative status in STZ-diabetic rats.
    Stocker P; Cassien M; Vidal N; Thétiot-Laurent S; Pietri S
    Talanta; 2017 Aug; 170():119-127. PubMed ID: 28501147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of myeloperoxidase-derived oxidants on the product profile of human 5-lipoxygenase.
    Zschaler J; Dorow J; Schöpe L; Ceglarek U; Arnhold J
    Free Radic Biol Med; 2015 Aug; 85():148-56. PubMed ID: 25912480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity.
    Panasenko OM; Ivanov VA; Mikhalchik EV; Gorudko IV; Grigorieva DV; Basyreva LY; Shmeleva EV; Gusev SA; Kostevich VA; Gorbunov NP; Sokolov AV
    Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36421449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor.
    Zhang H; Jing X; Shi Y; Xu H; Du J; Guan T; Weihrauch D; Jones DW; Wang W; Gourlay D; Oldham KT; Hillery CA; Pritchard KA
    J Lipid Res; 2013 Nov; 54(11):3016-29. PubMed ID: 23883583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury.
    Kubota K; Saiwai H; Kumamaru H; Maeda T; Ohkawa Y; Aratani Y; Nagano T; Iwamoto Y; Okada S
    Spine (Phila Pa 1976); 2012 Jul; 37(16):1363-9. PubMed ID: 22322369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid.
    Allegra M; Furtmüller PG; Jantschko W; Zederbauer M; Tesoriere L; Livrea MA; Obinger C
    Biochem Biophys Res Commun; 2005 Jul; 332(3):837-44. PubMed ID: 15913556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitive Effects of Quercetin on Myeloperoxidase-Dependent Hypochlorous Acid Formation and Vascular Endothelial Injury.
    Lu N; Sui Y; Tian R; Peng YY
    J Agric Food Chem; 2018 May; 66(19):4933-4940. PubMed ID: 29708335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid.
    Ximenes VF; Paino IM; Faria-Oliveira OM; Fonseca LM; Brunetti IL
    Braz J Med Biol Res; 2005 Nov; 38(11):1575-83. PubMed ID: 16258625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.